证券代码：600389 证券简称：江山股份 公告编号：临 2024-035 本次会议是否有否决议案：无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 54 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 176,173,322 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 39.7248 | (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会由公司董事会召集，现场会议由董事长薛健先生主持，会议采 南通江山农药化工股份有限公司 2023 年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： (一) 股东大会召开的时间：2024 年 05 月 15 日 (二) 股东大会召开的地点：南通江山农药化工股份有限公司会议室（江苏省 南通经济技术开发区江山路 998 号） (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 用现场投票与网络投 ...

证券代码：600389 证券简称：江山股份 公告编号：临 2024—034 6、注册资本：333,500 万元人民币 7、成立日期：2024 年 5 月 13 日 南通江山农药化工股份有限公司 关于对外投资设立参股公司的进展公告 8、经营范围：法律、法规、国务院决定规定禁止的不得经营；法律、法规、 国务院决定规定应当许可（审批）的，经审批机关批准后凭许可（审批）文件经 营；法律、法规、国务院决定规定无需许可（审批）的，市场主体自主选择经营。 化工产品销售（不含许可类化工产品）；热力生产和供应；供电业务；住房租赁； 非居住房地产租赁；化肥销售；肥料销售；食品添加剂销售；食品添加剂生产； 专用化学产品制造（不含危险化学品）；饲料添加剂生产；肥料生产；危险废物 2、统一社会信用代码：91522725MADK3YB243 3、类型：其他有限责任公司 4、住所：贵州瓮安经济开发区瓮福江山化工产业园区 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 南通江山农药化工股份有限公司（以下简称"公司"）分别于 2023 年 12 月 28 日召 ...

2024 年 4 月 25 日 公司研究 农药量价齐降 23 年业绩承压，发布股权激励计划彰显长期发展信心 ——江山股份（600389.SH）2023 年年度报告及 2024 年一季报点评 | --- | --- | --- | --- | --- | |-------------------------------|--------------------------------------------|----------------------------------------|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 当前价： | ...

南通江山农药化工股份有限公司（以下简称"公司"）于 2024 年 4 月 23 日 收到 5%以上股东四川省乐山市福华作物保护科技投资有限公司（以下简称"福 华科技"）《关于持有江山股份的权益变动超过 1%的告知函》，福华科技于 2024 年 4 月 12 日-2024 年 4 月 23 日通过大宗交易方式累计减持公司股份 8,860,000 股，变动比例达到公司总股本的 2.00%。现将有关权益变动情况公告如下： 一、本次权益变动基本情况 证券代码：600389 证券简称：江山股份 公告编号：临2024—033 南通江山农药化工股份有限公司 关于股东权益变动超过 1%的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: | 变动方式 | | 变动日期 | | | | 股份种类 | 减持股数 | 减持比例 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | （股） | （%） | | 大宗交易 | 2024 ...

南通江山农药化工股份有限公司 2023 年度 内部控制审计报告 索引 页码 内部控制审计报告 1-2 南通江山农药化工股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求,我们审计 了南通江山农药化工股份有限公司(以下简称江山股份公司)2023年12月31日财务报 告内部控制的有效性。 一、 企业对内部控制的责任 按照《企业内部控制基本规范》 、《企业内部控制应用指引》 《企业内部控制评 价指引》的规定,建立健全和有效实施内部控制,并评价其有效性是江山股份公司董事 会的责任。 二、 注册会计师的责任 联系电话: +86(010) 6554 2288 言永中和会计师事务所| 北京市东城区朝阳门北大街 telephone: +86 (010) 6554 2288 8 号富华大厦 A 座 9 层 内部控制审计报告 XYZH/2024SUAA2B0091 南通江山农药化工股份有限公司 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表审计意 见,并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、 内部控制的固有局限性 内部控制具有固有局限性,存在不能防止和发现错 ...

证券代码：600389 证券简称：江山股份 公告编号：临 2024-024 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司自律监管指引第 3 号行业信息披露：第十三 号—化工》、《关于做好主板上市公司 2023 年年度报告披露工作的通知》的要求， 南通江山农药化工股份有限公司（以下简称"公司"）现将 2023 年度主要经营数 据披露如下： 注 1：上述产量含自用量、农药按含量折原药计算（下同）。 注 2：除草剂产品包括草甘膦、酰胺类等产品；杀虫剂产品包括敌百虫、敌敌畏、二嗪 磷等产品；氯碱产品包括烧碱、盐酸、液氯、次氯酸钠等产品，其中烧碱产销量 按 32%、48%烧碱实物量计算（下同）。 注 3：阻燃剂（磷系）产品包含 TCPP、BDP 产品（下同）。 二、主要产品的价格变动情况（不含税） | | 2023 年 1-12 | | 月 | 2022 | 年 | 1-12 | 月 | 同期变动比 | | 第四季度环 | | --- | --- | --- | --- | --- | --- | --- ...

Financial Performance - The company's operating revenue for Q1 2024 was CNY 1,585,034,690.16, representing a year-on-year increase of 17.18%[5]. - Total revenue for Q1 2024 reached ¥1,585,034,690.16, an increase of 17.1% compared to ¥1,352,672,296.69 in Q1 2023[17]. - Operating profit for Q1 2024 was ¥108,036,941.63, down 29.4% from ¥153,025,794.85 in Q1 2023[18]. - Net profit for Q1 2024 was ¥84,985,087.54, a decrease of 31.1% compared to ¥123,622,745.10 in Q1 2023[18]. - Total comprehensive income for Q1 2024 was approximately ¥85.10 million, a significant decrease from ¥123.73 million in Q1 2023[19]. Profitability Metrics - The net profit attributable to shareholders decreased by 33.49% to CNY 82,236,390.36, primarily due to a decline in gross margin[5][8]. - Basic and diluted earnings per share both fell by 33.49% to CNY 0.1910[5][8]. - Basic and diluted earnings per share for Q1 2024 were ¥0.1910, down from ¥0.2871 in Q1 2023[19]. - The weighted average return on equity decreased by 1.3978 percentage points to 2.2622%[6]. Cash Flow and Liquidity - The net cash flow from operating activities was negative at CNY -68,378,030.19, a decrease of 170.63% compared to the previous year, attributed to reduced sales collections[5][8]. - Net cash flow from operating activities was -¥68.38 million, down from ¥96.81 million in the same period last year[22]. - Cash and cash equivalents increased to ¥797,674.16 in Q1 2024 from ¥241,592.10 in Q1 2023[13]. - Cash and cash equivalents at the end of Q1 2024 totaled ¥2.18 billion, a decrease from ¥1.95 billion at the end of Q1 2023[23]. - Cash outflow from investing activities was ¥171.73 million, compared to ¥72.70 million in Q1 2023, indicating increased investment expenditures[22]. - Cash inflow from financing activities was ¥50 million, with net cash flow from financing activities improving to ¥23.88 million from -¥5.75 million in Q1 2023[23]. Assets and Liabilities - Total assets at the end of Q1 2024 were CNY 6,622,931,500.49, a decrease of 0.79% from the end of the previous year[6]. - Total assets as of Q1 2024 amounted to ¥6,622,931,500.49, slightly down from ¥6,675,368,502.79 in Q1 2023[14]. - Total liabilities decreased to ¥2,823,664,905.94 in Q1 2024 from ¥2,976,278,584.36 in Q1 2023[14]. - The equity attributable to shareholders increased by 2.71% to CNY 3,688,172,994.61 compared to the end of the previous year[6]. - The total equity attributable to shareholders increased to ¥3,688,172,994.61 in Q1 2024 from ¥3,590,745,015.68 in Q1 2023[15]. Operational Highlights - The increase in operating revenue was mainly driven by a rise in sales volume of certain pesticide products during the reporting period[8]. - The company had a total of 25,302 common shareholders at the end of the reporting period[10]. - Research and development expenses rose to ¥49,970,406.04 in Q1 2024, up from ¥42,249,446.03 in Q1 2023[18]. - The company plans to continue focusing on market expansion and new product development in the upcoming quarters[16]. - The company reported a decrease in inventory to ¥761,407,625.30 in Q1 2024 from ¥816,919,480.43 in Q1 2023[13]. Non-Recurring Items - Non-recurring gains and losses amounted to CNY 2,345,732.21, with government subsidies contributing CNY 2,989,213.40[7]. - The company received ¥14.07 million in tax refunds during Q1 2024, down from ¥19.62 million in Q1 2023[21]. - The company reported an increase in cash received from other operating activities to ¥61.63 million, compared to ¥11.05 million in the previous year[22]. - The company did not report any net profit from subsidiaries prior to consolidation in the current or previous periods[19].

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、日常关联交易基本情况 南通江山农药化工股份有限公司 关于公司 2024 年日常关联交易的公告 （一）日常关联交易履行的审议程序 1、董事会表决情况和关联董事回避情况 证券代码：600389 证券简称：江山股份 公告编号：临 2024—028 （1）与公司第一大股东关联企业的日常关联交易事项，关联董事薛健、顾 建国、陈云光回避表决，其余 6 名非关联董事一致同意。 （2）与公司其他关联方的日常关联交易事项，无关联董事回避表决，9 名 非关联董事一致同意。 2、独立董事专门会议 公司独立董事认为：公司 2024 年度日常关联交易，是因公司正常的生产经 营需要而发生的，可以发挥公司与关联方的协同效应，促进公司的业务发展。交 易遵循了公开、公平、公正的原则，不存在损害本公司和广大股东利益的情况， 1 公司2024年日常关联交易预计发生额未超过公司最近一期经审计净资产 的5%，根据《上海证券交易所股票上市规则》的规定，无需提交公司股 东大会审议批准。 日常关联交易所涉及 ...

Financial Performance - The company's basic earnings per share (EPS) for 2023 is 0.6542 CNY, a decrease of 84.51% compared to 4.2246 CNY in 2022[21]. - The net profit attributable to shareholders for 2023 is 282,952,031.26 CNY, down 84.66% from 1,844,424,518.46 CNY in 2022[22]. - Operating revenue for 2023 is 5,085,696,347.20 CNY, a decline of 39.08% from 8,348,772,840.84 CNY in 2022[22]. - The weighted average return on equity (ROE) decreased to 8.14% in 2023, down 52.71 percentage points from 60.85% in 2022[21]. - The net cash flow from operating activities for 2023 is 770,018,562.27 CNY, a decrease of 56.59% compared to 1,773,699,279.71 CNY in 2022[22]. - The company's total assets increased by 2.49% to 6,675,368,502.79 CNY at the end of 2023, compared to 6,513,098,085.61 CNY at the end of 2022[22]. - Gross profit for 2023 was 683 million RMB, down 19.91 billion RMB from the previous year, with an average gross margin dropping from 32.03% to 13.43%[42]. - The company reported a net cash flow from financing activities of 244,754,538.42, a significant improvement compared to a negative cash flow of -764,069,012.04 in the previous year[61]. Corporate Governance - The company has received a standard unqualified audit report from Xinyong Zhonghe Accounting Firm[5]. - The company has not violated decision-making procedures for external guarantees[8]. - The company has established a robust governance structure to ensure fair treatment of all shareholders[119]. - The company maintains independence from major shareholders to protect its operational integrity and decision-making processes[120]. - The board of directors and supervisory board held regular meetings, adhering to established rules and procedures[124]. - The company has not faced any regulatory issues requiring corrective actions during the reporting period[123]. - The company has not disclosed any significant deficiencies in internal controls during the reporting period[166]. - The company has publicly disclosed the names and positions of the proposed incentive plan participants without receiving any objections[163]. Risk Management - The company faces risks related to safety, environmental protection, market fluctuations, industry policy changes, raw material price volatility, and exchange rate fluctuations[8]. - The company emphasized risk management by enhancing internal control measures in line with regulatory requirements[123]. - The company has conducted an annual risk reassessment to identify and track risks and control measures quarterly[165]. - The company is actively managing foreign exchange risks through financial derivatives to stabilize earnings[116]. Environmental Commitment - The company is committed to environmental protection and social welfare while maximizing shareholder value[123]. - The company invested 9,650,000 RMB in environmental protection during the reporting period[169]. - The company maintained compliance with the "Comprehensive Wastewater Discharge Standards" (GB8978-1996) and achieved a COD discharge concentration of 130.5 mg/L, significantly below the limit of 500 mg/L[175]. - The company continues to hold the title of "Green" in environmental credit ratings and has been recognized as an A-level enterprise in provincial key industry performance evaluations[170]. - The company has implemented online monitoring systems for wastewater, rainwater, and waste gas, ensuring real-time data transmission to environmental authorities[171]. - The company has successfully maintained compliance with all environmental regulations, with no projects built without prior approval[179]. Strategic Initiatives - The company plans to focus on integrating management systems to enhance operational efficiency and safety standards[40]. - The company is focusing on developing efficient, safe, and environmentally friendly pesticides as a key trend in the industry[104]. - The company is set to accelerate the construction of its second and third bases, including a 100,000-ton intelligent formulation project[107]. - The company is focusing on expanding its market presence through new product development and strategic investments[150]. - The company plans to enhance its digital infrastructure, with an investment of 150 million to improve user experience and data analytics capabilities[130]. Research and Development - The company completed R&D investments of CNY 149.11 million in 2023, conducting 25 research projects and launching 16 new formulation products[80]. - The company has applied for 25 patents in 2023, including 22 invention patents, and has received 26 patent authorizations, with 21 being invention patents[80]. - The company is investing heavily in R&D, with a budget allocation of 883.35 million for the development of new technologies and products[130]. Shareholder Engagement - The company reported a significant increase in shareholder engagement, ensuring transparency and compliance with information disclosure regulations[123]. - The company plans to implement a three-year shareholder return plan from 2023 to 2025[127]. - The chairman of the board, Xue Jian, increased his shareholding from 861,119 to 1,027,180 shares during the reporting period, reflecting a change of 166,061 shares[129]. - The vice chairman, Liu Weidong, increased his shareholding from 587,200 to 769,950 shares, with a change of 182,750 shares[129]. Operational Efficiency - The company implemented cost reduction measures resulting in savings exceeding 50 million yuan for the year[31]. - The company is focusing on cost reduction and efficiency improvement to enhance operational quality[110]. - The company reported a decrease in operational costs by 10% due to improved supply chain management[134]. Market Position - The global crop protection market reached 74.755 billion USD in 2022, with a year-on-year growth of 13.7%[72]. - The company is one of the first to pass the HSE audit in the pesticide industry, enhancing its safety management level[39]. - The company has established strategic cooperation with core raw material suppliers to enhance supply chain security[31]. - The company is targeting high-quality development by focusing on major project advancements and enhancing internal growth momentum[109].

南通江山农药化工股份有限公司 2023 年度独立董事述职报告 作为南通江山农药化工股份有限公司的独立董事，本人严格按照《公司法》、 《证券法》、《上市公司独立董事管理办法》、《上海证券交易所股票上市规则》等 相关法律法规的要求，以及《公司章程》、《独立董事工作制度》的规定，本着独 立诚信、勤勉尽责的工作态度，按时出席公司股东大会、董事会及董事会各专门 委员会会议，慎重审议各项议案，全面关注公司的发展状况，忠实履行职责，充 分发挥独立董事的独立作用，切实维护了公司以及全体股东的合法权益。现将 2023 年度独立董事工作情况汇报如下： 一、独立董事的基本情况 （一）个人工作履历、专业背景以及兼职情况 张利军，男，1976年出生，大学学历，硕士学位，一级律师。现任江苏法德 东恒律师事务所执委会主席，兼任江苏省律师协会副会长、南京市人大常委会委 员、中国国际经济贸易仲裁委员会仲裁员，同时兼任江苏国信（002608）、协鑫 集成（002506）、宝胜股份（600973）独立董事（已于2023年12月12日披露辞职 公告，待宝胜股份召开股东大会选举新任独立董事后生效）。2020年1月16日至今 任公司独立董事。 （二）独 ...